Christine Winoto, Director, Rosenman Institute; Deputy Director, QB3

Christine Winoto manages QB3’s international programs, the JPMorgan Chase program, the Rosenman Institute and operations. Before joining QB3, she developed marketing strategy and analyzed performance for Kaiser Permanente, and managed business development and business analysis at Genencor. In addition to consulting for startups and venture capital, she has also held R&D and operations positions in medical device companies including Physiometrix (IPO, then acquired by Hospira), Cardiovasc and Heartport. Christine holds an MBA from Erasmus University in the Netherlands and a BS in food chemistry from the University of Wisconsin, Madison.